These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 21415954)
21. Transjugular intrahepatic portosystemic shunt may be superior to conservative therapy for variceal rebleeding in cirrhotic patients with non-tumoral portal vein thrombosis: a hypothesis. Qi X; Han G; He C; Yin Z; Zhang H; Wang J; Xia J; Cai H; Yang Z; Bai M; Wu K; Fan D Med Sci Monit; 2012 Aug; 18(8):HY37-41. PubMed ID: 22847208 [TBL] [Abstract][Full Text] [Related]
22. Nontumoral Portal Vein Thrombosis: A Challenging Consequence of Liver Cirrhosis. Rugivarodom M; Charatcharoenwitthaya P J Clin Transl Hepatol; 2020 Dec; 8(4):432-444. PubMed ID: 33447527 [TBL] [Abstract][Full Text] [Related]
23. Cirrhosis of liver and portal vein thrombosis - a review article. Debnath CR; Debnath MR; Alam MM; Moshwan MM; Alam MJ; Rana MS; Biswas D; Mahmuduzzaman M; Tarafder AJ Mymensingh Med J; 2014 Jul; 23(3):606-8. PubMed ID: 25178622 [TBL] [Abstract][Full Text] [Related]
24. Portal Vein Thrombosis in Adult Omani Patients: A Retrospective Cohort Study. Al Hashmi K; Al Aamri L; Al Lamki S; Pathare A Oman Med J; 2017 Nov; 32(6):522-527. PubMed ID: 29218132 [TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis. Delgado MG; Seijo S; Yepes I; Achécar L; Catalina MV; García-Criado A; Abraldes JG; de la Peña J; Bañares R; Albillos A; Bosch J; García-Pagán JC Clin Gastroenterol Hepatol; 2012 Jul; 10(7):776-83. PubMed ID: 22289875 [TBL] [Abstract][Full Text] [Related]
26. Causes of portal venous thrombosis in cirrhotic patients: the role of genetic and acquired factors. Mangia A; Villani MR; Cappucci G; Santoro R; Ricciardi R; Facciorusso D; Leandro G; Caruso N; Andriulli A Eur J Gastroenterol Hepatol; 2005 Jul; 17(7):745-51. PubMed ID: 15947552 [TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of anticoagulation therapy with different doses of enoxaparin for portal vein thrombosis in cirrhotic patients with hepatitis B. Cui SB; Shu RH; Yan SP; Wu H; Chen Y; Wang L; Zhu Q Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):914-9. PubMed ID: 25856686 [TBL] [Abstract][Full Text] [Related]
29. Agitation thrombolysis combined with catheter-directed thrombolysis for the treatment of non-cirrhotic acute portal vein thrombosis. Wang CY; Wei LQ; Niu HZ; Gao WQ; Wang T; Chen SJ World J Gastroenterol; 2018 Oct; 24(39):4482-4488. PubMed ID: 30357003 [TBL] [Abstract][Full Text] [Related]
30. Portal vein thrombosis: what is new? Manzano-Robleda Mdel C; Barranco-Fragoso B; Uribe M; Méndez-Sánchez N Ann Hepatol; 2015; 14(1):20-7. PubMed ID: 25536638 [TBL] [Abstract][Full Text] [Related]
31. Natural history of patients with non cirrhotic portal hypertension: Comparison with patients with compensated cirrhosis. Gioia S; Nardelli S; Pasquale C; Pentassuglio I; Nicoletti V; Aprile F; Merli M; Riggio O Dig Liver Dis; 2018 Aug; 50(8):839-844. PubMed ID: 29429910 [TBL] [Abstract][Full Text] [Related]
32. [Clinical features of liver cirrhosis complicated by portal vein thrombosis and related risk factors]. Lin GS; Xu Q; Zhao SY; Zhang YX Zhonghua Gan Zang Bing Za Zhi; 2016 Jul; 24(7):513-517. PubMed ID: 27784429 [No Abstract] [Full Text] [Related]
33. Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up. Cai M; Zhu K; Huang W; Meng X; He K; Zhou B; Guo Y; Chen J; Shan H J Vasc Interv Radiol; 2013 Dec; 24(12):1808-16. PubMed ID: 24099787 [TBL] [Abstract][Full Text] [Related]